CURA CARE
Patients: How pharma, governments will change post-Glivec rulingThe Supreme Court’s landmark judgment on the Novartis Glivec case — disallowing a patent on minor modifications — has started a global deba...10 Apr, 2013, 04.22 AM IST
Load More